litlas
ログインアカウント作成

Paul Dent

1990–2024 年に発表

160
論文数
23,965
被引用数
97
h 指数
158
i10 指数

被引用数

Paul Dent の年別被引用数1973 年: 被引用 1 件1981 年: 被引用 1 件1991 年: 被引用 14 件1992 年: 被引用 31 件1993 年: 被引用 96 件1994 年: 被引用 162 件1995 年: 被引用 185 件1996 年: 被引用 148 件1997 年: 被引用 135 件1998 年: 被引用 119 件1999 年: 被引用 175 件2000 年: 被引用 167 件2001 年: 被引用 206 件2002 年: 被引用 257 件2003 年: 被引用 323 件2004 年: 被引用 343 件2005 年: 被引用 283 件2006 年: 被引用 285 件2007 年: 被引用 283 件2008 年: 被引用 255 件2009 年: 被引用 269 件2010 年: 被引用 305 件2011 年: 被引用 303 件2012 年: 被引用 226 件2013 年: 被引用 223 件2014 年: 被引用 250 件2015 年: 被引用 179 件2016 年: 被引用 144 件2017 年: 被引用 143 件2018 年: 被引用 140 件2019 年: 被引用 513 件2020 年: 被引用 473 件2021 年: 被引用 489 件2022 年: 被引用 302 件2023 年: 被引用 194 件2024 年: 被引用 282 件2025 年: 被引用 137 件2026 年: 被引用 2 件1974〜1980 年は被引用が無いため表示していません1982〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,981 件、この内訳の 36.6%中国: 引用元論文 971 件、この内訳の 11.9%イギリス: 引用元論文 435 件、この内訳の 5.3%ドイツ: 引用元論文 413 件、この内訳の 5.1%イタリア: 引用元論文 288 件、この内訳の 3.5%日本: 引用元論文 271 件、この内訳の 3.3%フランス: 引用元論文 266 件、この内訳の 3.3%カナダ: 引用元論文 225 件、この内訳の 2.8%インド: 引用元論文 197 件、この内訳の 2.4%韓国: 引用元論文 162 件、この内訳の 2%スペイン: 引用元論文 160 件、この内訳の 2%オーストラリア: 引用元論文 155 件、この内訳の 1.9%
0%36.6%その他 19.9%

機関

分野

  • Biochemistry, Genetics and Molecular Biology51%
  • Medicine39.5%
  • Immunology and Microbiology2.8%
  • Neuroscience1.4%
  • Computer Science1.2%
  • Agricultural and Biological Sciences0.8%
  • その他3.3%

トピック

  • Protein Kinase Regulation and GTPase Signaling3.6%
  • Melanoma and MAPK Pathways2.8%
  • Cell death mechanisms and regulation2.8%
  • Autophagy in Disease and Therapy2.7%
  • Drug Transport and Resistance Mechanisms2.5%
  • PI3K/AKT/mTOR signaling in cancer2%
  • その他83.6%

共著者

全論文

検索で開く
  1. Bile acids as regulatory molecules

    著者: Phillip B. Hylemon, Huiping Zhou, William M. Pandak, Shunlin Ren, Gregorio Gil, Paul Dent - Journal of Lipid Research 2009 被引用: 693

  2. Conjugated Bile Acids Activate the Sphingosine–1–Phosphate Receptor 2 in Primary Rodent Hepatocytes

    著者: Elaine Studer, Xiqiao Zhou, Renping Zhao, Yun Wang, Kazuaki Takabe, Masayuki Nagahashi, William M. Pandak, Paul Dent, Sarah Spiegel, Ruihua Shi, Weiren Xu, Xuyuan Liu, Pat Bohdan, Luyong Zhang, Huiping Zhou, Phillip B. Hylemon - Hepatology 2011 被引用: 316

  3. Targeting the Bcl-2 family for cancer therapy

    著者: Shibu Thomas, Bridget A. Quinn, Swadesh K. Das, Rupesh Dash, Luni Emdad, Santanu Dasgupta, Xiang‐Yang Wang, Paul Dent, John C. Reed, Maurizio Pellecchia, Devanand Sarkar, Paul B. Fisher - Expert Opinion on Therapeutic Targets 2012 被引用: 267

  4. Autophagy

    著者: Sujit K. Bhutia, Subhadip Mukhopadhyay, Niharika Sinha, Durgesh Nandini Das, Prashanta Kumar Panda, Samir Kumar Patra, Tapas K. Maiti, Mahitosh Mandal, Paul Dent, Xiangyang Wang, Swadesh K. Das, Devanand Sarkar, Paul B. Fisher - Advances in cancer research 2013 被引用: 221

  5. Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727

    著者: Qifang Zhang, Vidisha Raje, Vasily A. Yakovlev, Adly Yacoub, Karol Szczepanek, Jeremy A. Meier, Marta Derecka, Qun Chen, Ying Hu, Jennifer D. Sisler, Hossein A. Hamed, Edward J. Lesnefsky, Kristoffer Valerie, Paul Dent, Andrew C. Larner - Journal of Biological Chemistry 2013 被引用: 182

  6. The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib

    著者: Laurence Booth, Jane L. Roberts, Paul Dent - Seminars in Cancer Biology 2019 被引用: 83

  7. MAPK pathways in radiation responses

    著者: Paul Dent, Adly Yacoub, Paul B. Fisher, Michael P. Hagan, Steven Grant - Oncogene 2003 被引用: 603

  8. The role of cell signalling in the crosstalk between autophagy and apoptosis

    著者: Laurence Booth, Seyedmehrad Tavallai, Hossein A. Hamed, Nichola Cruickshanks, Paul Dent - Cellular Signalling 2013 被引用: 341

  9. HDAC inhibitors enhance the immunotherapy response of melanoma cells

    著者: Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John M. Kirkwood, Paul Dent - Oncotarget 2017 被引用: 136

  10. The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress

    著者: Mohamed Rahmani, Eric Maynard Davis, Timothy Ryan Crabtree, Joseph Habibi, Tri K. Nguyen, Paul Dent, Steven Grant - Molecular and Cellular Biology 2007 被引用: 250

  11. Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

    著者: Anindita Das, David Durrant, Clint Mitchell, Eric K. Mayton, Nicholas N Hoke, Fadi N. Salloum, Margaret A. Park, Ian Qureshi, Ray Lee, Paul Dent, Rakesh C. Kukreja - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 被引用: 161

  12. (Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo

    著者: Paul Dent, Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John F. Hancock - Journal of Cellular Physiology 2020 被引用: 44

  13. Radiation-induced cell signaling: inside-out and outside-in

    著者: Kristoffer Valerie, Adly Yacoub, Michael P. Hagan, David T. Curiel, Paul B. Fisher, Steven Grant, Paul Dent - Molecular Cancer Therapeutics 2007 被引用: 327

  14. Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells

    著者: Paul Dent, Laurence Booth, Jane L. Roberts, Junchen Liu, Andrew Poklepovic, Alshad S. Lalani, David A. Tuveson, Jennifer Martinez, John F. Hancock - Oncogene 2019 被引用: 85

  15. Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery Approach

    著者: Adelaide Greco, Altomare Di Benedetto, Candace M. Howard, Sarah Kelly, Rounak Nande, Yulia Dementieva, Michele Miranda, Arturo Brunetti, Marco Salvatore, Luigi Claudio, Devanand Sarkar, Paul Dent, David T. Curiel, Paul B. Fisher, Pier Paolo Claudio - Molecular Therapy 2009 被引用: 81

  16. Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancer

    著者: Paul Dent - Expert Opinion on Investigational Drugs 2019 被引用: 59

  17. Alteration of Ceramide Synthase 6/C16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network

    著者: Can E. Senkal, Suriyan Ponnusamy, Yefim Manevich, Marisa Meyers‐Needham, Sahar A. Saddoughi, Archana Mukhopadyay, Paul Dent, Jacek Bielawski, Besim Öğretmen - Journal of Biological Chemistry 2011 被引用: 135

  18. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes

    著者: Youwen Fang, Song Iy Han, Clint Mitchell, Seema Gupta, Elaine Studer, Steven Grant, Phillip B. Hylemon, Paul Dent - Hepatology 2004 被引用: 130

  19. Crosstalk between ERK, AKT, and cell survival

    著者: Paul Dent - Cancer Biology & Therapy 2014 被引用: 97

  20. Deoxycholic Acid (DCA) Causes Ligand-independent Activation of Epidermal Growth Factor Receptor (EGFR) and FAS Receptor in Primary Hepatocytes: Inhibition of EGFR/Mitogen-activated Protein Kinase-Signaling Module Enhances DCA-induced Apoptosis

    著者: Liang Qiao, Elaine Studer, Kevin Leach, Robert McKinstry, Seema Gupta, Roy H. Decker, Rakesh C. Kukreja, Kristoffer Valerie, Prakash Nagarkatti, Wafik S. El‐Deiry, Jeffery D. Molkentin, Rupert Schmidt‐Ullrich, Paul B. Fisher, Steven Grant, Philip B. Hylemon, Paul Dent - Molecular Biology of the Cell 2001 被引用: 233

  21. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes

    著者: Liang Qiao, Adly Yacoub, Elaine Studer, Seema Gupta, Xin Pei, Steven Grant, Philip B. Hylemon, Paul Dent - Hepatology 2002 被引用: 144

  22. Autocrine regulation of mda -7/IL-24 mediates cancer-specific apoptosis

    著者: Moira Sauane, Zao-zhong Su, Pankaj Gupta, Irina V. Lebedeva, Paul Dent, Devanand Sarkar, Paul B. Fisher - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 被引用: 121

  23. Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma

    著者: Sarah Gordon, William P. McGuire, Danielle Shafer, Richard K. Sterling, Hannah M. Lee, Scott Matherly, John D. Roberts, Prithviraj Bose, Mary Beth Tombes, E. Ellen Shrader, Alison A. Ryan, Maciej Kmieciak, Tri Nguyen, Xiaoyan Deng, Dipankar Bandyopadhyay, Paul Dent, Andrew Poklepovic - American Journal of Clinical Oncology 2019 被引用: 41

  24. Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance

    著者: Nathan T. Ihle, Robert Lemos, Peter Wipf, Adly Yacoub, Clint Mitchell, Doris R. Siwak, Gordon B. Mills, Paul Dent, D. Lynn Kirkpatrick, Garth Powis - Cancer Research 2008 被引用: 274